Illumina, Inc. (ILMN): Acquisition News

ILMN – Acquires Edico Genome, the provider of data analysis acceleration solutions for next-generation sequencing; terms not disclosed.

Key Facts Surrounding This News Item

  • ILMN had a POWR Rating of A (Strong Buy) coming into today.
  • ILMN was 5.86% above its 10-Day Moving Average coming into today.
  • ILMN was 8.26% above its 20-Day Moving Average coming into today.
  • ILMN was 10.28% above its 50-Day Moving Average coming into today.
  • ILMN was 13.81% above its 100-Day Moving Average coming into today.
  • ILMN was 21.88% above its 200-Day Moving Average coming into today.
  • ILMN had returned +23.32% year-to-date leading up to today’s news, versus a +2.70% return from the benchmark S&P 500 during the same period.

More Info About Illumina, Inc. (ILMN)

Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. The company’s products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. The company was founded in 1998 and is based in San Diego, California. View our full ILMN ticker page with ratings, news, and more.

ILMN at a Glance

ILMN Current POWR Rating™
Overall POWR Rating™
ILMN Current Price $310.05 1.45%
More ILMN Ratings, Data, and News

ILMN Price Reaction

The day of this event (May. 15, 2018)
ILMN Closing Price$263.75 2.11%
ILMN Volume749,100
14.11% from avg
Leading up to this event
ILMN 1-mo returnN/A%
After this event
ILMN 1-day return0.22%
ILMN 3-day return0.09%
ILMN 5-day return0.50%

ILMN Price Chart

The Top Stocks For 2019

More Illumina, Inc. (ILMN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ILMN News
Page generated in 0.7884 seconds.